Status:
COMPLETED
The RECORD Asia-Pacific Atrial Fibrillation Registry
Lead Sponsor:
Sanofi
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices. The Secondary objectives are: * To ...
Eligibility Criteria
Inclusion
- Patient presenting with either:
- History of atrial fibrillation diagnosed \< 1 year by standard Electro-Cardiogram (ECG) or by ECG-Holter monitoring (treated or not or whatever rhythm at inclusion).
- New atrial fibrillation diagnosed by standard ECG or by ECG-Holter monitoring at inclusion visit.
- Patient eligible for a pharmacological treatment of AF (by rhythm or rate control agent).
Exclusion
- AF due to transient cause (thyrotoxicosis, alcohol intoxication, acute phase of myocardial infarction, pericarditis, myocarditis, electrocution, pulmonary embolism or other pulmonary disease, hydroelectrolytic disorder, metabolic disorder, etc.).
- Post cardiac surgery AF (≤3 months).
- Mentally disabled patients unable to understand or sign the written informed consent.
- Patients unable to comply with follow-up visits.
- Patients with pacemaker, Implantable Cardioverter Defibrillator (ICD).
- Patients scheduled for pulmonary vein ablation, AV node/His bundle ablation, or pacemaker implantation.
- Patient included in any clinical trial in the previous 3 months.
- Pregnant or breastfeeding women.
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
2674 Patients enrolled
Trial Details
Trial ID
NCT00995748
Start Date
April 1 2009
End Date
October 1 2011
Last Update
February 20 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
Macquarie Park, Australia
2
Sanofi-Aventis Administrative Office
Shanghai, China
3
Sanofi-Aventis Administrative Office
Hong Kong, Hong Kong
4
Sanofi-Aventis Administrative Office
Kuala Lumpur, Malaysia